iv glutathione als Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies Glutathione IV Therapy | IV
Description
72 LuoW.LinS.LiG.NieQ.ZhangX

Pefanis, A., Ierino, F

In a Phase III study, 82.3% of patientswho had residual anemia after anti-C5 treatmentsaw a sustained increase in hemoglobin levels even without transfusions compared with 0% of those who stayed on anti-C5 treatments

10.1038/sj.npp.1301534 70 MllerU.SteffenhagenN.RegenthalR.BublakP

In the UK, there are NICE guidelines stating what level of growth hormone deficiency qualifies for replacement medication

Jiang, Q
